CompletedNCT00330551
This study exists to compare options and see whether a guided support group offers something meaningfully different. Researchers are trying to understand whether a guided support group can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- University of California, Los Angeles
- Condition
- Schizophrenia
TerminatedNCT04404712
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
CompletedNCT02535923
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 80 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Schizophrenia
CompletedNCT03921450
This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- Switzerland
- Sponsor
- University of Bern
- Condition
- Schizophrenia
CompletedNCT04856657
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- University of Minnesota
- Condition
- Schizophrenia
TerminatedNCT03671005
This study exists to see whether a guided support group can make care clearer and more responsive. Researchers are trying to understand whether a guided support group can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Germany
- Sponsor
- Charite University, Berlin, Germany
- Condition
- Schizophrenia
CompletedNCT04010305
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- BioXcel Therapeutics Inc
- Condition
- Schizophrenia
CompletedNCT03810755
This study exists to understand what helps smoking support or smoking-related treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether smoking support or smoking-related treatment can better support energy, concentration, and everyday functioning.
SchizophreniaOtherFrom 18 Years to 75 Years
- Countries
- Spain
- Sponsor
- Basque Health Service
- Condition
- Schizophrenia
WithdrawnNCT03407443
This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 89 Years
- Countries
- Global
- Sponsor
- Canandaigua VA Medical Center
- Condition
- Schizophrenia
CompletedNCT03465787
This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
SchizophreniaOtherFrom 19 Years to 75 Years
- Countries
- South Korea
- Sponsor
- Bukwang Pharmaceutical
- Condition
- Schizophrenia
CompletedNCT04567524
This study exists to better understand the safety of a digital app or remote support tool and how manageable it feels in practice. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Lyndra Inc.
- Condition
- Schizophrenia
CompletedNCT05712928
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Drexel University
- Condition
- Schizophrenia
CompletedNCT03919994
This study exists to see whether the medication Long can play a useful role in care. Researchers are trying to understand what the medication Long could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Alkermes, Inc.
- Condition
- Schizophrenia
CompletedNCT02404155
This study exists to see whether the medication Clozapine is workable and worth testing more broadly. Researchers are trying to understand how people respond to the medication Clozapine in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
CompletedNCT04294719
This study exists to see whether the medication Cognitive is workable and worth testing more broadly. Researchers are trying to understand whether the medication Cognitive can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 18 Years
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health
- Condition
- Schizophrenia
CompletedNCT03769493
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Butler Hospital
- Condition
- Schizophrenia
CompletedNCT03281629
This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
CompletedNCT04799717
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 10 Years to 18 Years
- Countries
- United States
- Sponsor
- Stanford University
- Condition
- Schizophrenia
CompletedNCT03869177
This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand what helps a digital app or remote support tool stay useful, realistic, and easier to follow over time.
SchizophreniaOtherOver 18 Years
- Countries
- Norway
- Sponsor
- University of Oslo
- Condition
- Schizophrenia
CompletedNCT03860597
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia
CompletedNCT05245539
This study exists to explore whether the medication CVL-231 could improve care and understanding. Researchers are trying to understand what the medication CVL-231 can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 30 Years to 60 Years
- Countries
- United States
- Sponsor
- Cerevel Therapeutics, LLC
- Condition
- Schizophrenia
CompletedNCT02204787
This study exists to see whether this type of care can make care clearer and more responsive. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- France
- Sponsor
- University Hospital, Montpellier
- Condition
- Schizophrenia
CompletedNCT03893825
This study exists to understand how the medication TV-46000 holds up over time after the earliest research stage. Researchers are trying to understand whether the medication TV-46000 can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 13 Years to 65 Years
- Countries
- Bulgaria, Canada, France, Israel, United States
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Condition
- Schizophrenia
CompletedNCT04709224
This study exists to learn from real-world information that can show how a medication treatment fits into care. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Intra-Cellular Therapies, Inc.
- Condition
- Schizophrenia
CompletedNCT00982982
This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia